Canadian Drugmaker Apotex Seeks Up to $730 Million in First-Half IPO

Canadian generic drug manufacturer Apotex Inc. is looking at the first half of the year for an initial public offering in Toronto that could raise as much as C$1 billion ($730 million), according to people familiar with the matter....

Redirecting to full article...